These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 767112)

  • 1. The second generation of EORTC-ECIG experimental screening for systemic immunity adjuvants. Its significance for cancer immunotherapy. A comparison of BCG and its hydrosoluble extract.
    Mathe G; Halle-Pannenko O; Florentin I; Bruley-Rosset M; Kamel M; Hiu IJ; Bourut C
    Eur J Cancer (1965); 1975 Nov; 11(11):801-7. PubMed ID: 767112
    [No Abstract]   [Full Text] [Related]  

  • 2. BCG in cancer immunotherapy: results obtained with various BCG preparations in a screening study for systemic adjuvants applicable to cancer immunoprophylaxis or immunotherapy.
    Mathé G; Halle-Pannenko O; Bourut C
    Natl Cancer Inst Monogr; 1973 Dec; 39():107-13. PubMed ID: 4150738
    [No Abstract]   [Full Text] [Related]  

  • 3. The use of systemic immunity adjuvants in the prophylaxis or therapy of cancer.
    Mathé G; Halle-Pannenko O; Bourut C; Hiu IJ
    Johns Hopkins Med J Suppl; 1974; 3():85-102. PubMed ID: 4154074
    [No Abstract]   [Full Text] [Related]  

  • 4. Methanol extraction residue fraction of tubercle bacilli (MER) and other mycobacterial extracts as systemic immunity adjuvants in cancer immunotherapy.
    Mathé G; Hiu IJ; Halle-Pannenko O; Bourut C
    Isr J Med Sci; 1976; 12(4-5):468-71. PubMed ID: 820673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental screening for "systemic adjuvants of immunity" applicable in cancer immunotherapy.
    Mathé G; Kamel M; Dezfulian M; Halle-Pannenko O; Bourut C
    Cancer Res; 1973 Sep; 33(9):1987-97. PubMed ID: 4146853
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunotherapy of guinea pig cancer with BCG.
    Zbar B
    Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
    [No Abstract]   [Full Text] [Related]  

  • 7. Activated macrophages and the antitumor action of BCG.
    Alexander P
    Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
    [No Abstract]   [Full Text] [Related]  

  • 8. Experimental and clinical trials with BCG immunotherapy.
    Sparks FC; Silverstein MJ; Hunt JS; O'Connell TX; Lee YT; Pilch YH; Haskell CM; Morton DL
    Johns Hopkins Med J Suppl; 1974; 3():103-20. PubMed ID: 4609024
    [No Abstract]   [Full Text] [Related]  

  • 9. Nonspecific macrophage activation by systemic adjuvants. Evaluation by lysosomal enzyme and in vitro tumoricidal activities.
    Bruley-Rosset M; Florentin I; Khalil AM; Mathé G
    Int Arch Allergy Appl Immunol; 1976; 51(5):594-607. PubMed ID: 786904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo and in vitro macrophage activation by systemic adjuvants.
    Bruley-Rosset M; Florentin I; Mathé G
    Agents Actions; 1976 Feb; 6(1-3):251-5. PubMed ID: 782207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological intervention in neoplasia.
    Weiss DW
    Johns Hopkins Med J Suppl; 1974; 3():131-56. PubMed ID: 4371312
    [No Abstract]   [Full Text] [Related]  

  • 12. Adjuvant and antitumor activities of Nocardia cell-wall skeletons.
    Azuma I; Taniyama T; Yamawaki M; Sugimura K; Yamamura Y
    Gan; 1976 Oct; 67(5):733-6. PubMed ID: 797626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor immunity induced by BCG-tumor cell mixtures in syngeneic mice.
    Tokunaga T; Kataoka T; Nakamura RM; Yamamoto S; Tanaka T
    Jpn J Med Sci Biol; 1973 Apr; 26(2):71-85. PubMed ID: 4585343
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative antitumoral cytostatic effect of splenic or peritoneal cells of mice with teratocarcinoma or immunized with tumoral cells. Stimulating effect of BCG and cyclophosphamide].
    Christen Y
    C R Acad Hebd Seances Acad Sci D; 1974 Nov; 279(22):1729-32. PubMed ID: 4219181
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison between the effects of Micrococcus, BCG and related polysaccharides in preclinical chemo-immunotherapy of murine L 1210 leukaemia [proceedings].
    Verloes R; Atassi G; Dumont P; Kanarek L
    Arch Int Physiol Biochim; 1978 Oct; 86(4):969-71. PubMed ID: 84653
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
    Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
    Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunology and colonic cancer: cancer immunotherapy results in leukemias--experimental and clinical approaches to the treatment of solid tumors.
    Mathé G; Thompson RB
    Dis Colon Rectum; 1973; 16(5):341-57. PubMed ID: 4590448
    [No Abstract]   [Full Text] [Related]  

  • 18. BCG in tumor immunotherapy.
    Baldwin RW; Pimm MV
    Adv Cancer Res; 1978; 28():91-147. PubMed ID: 360797
    [No Abstract]   [Full Text] [Related]  

  • 19. BCG in cancer immunotherapy: experimental and clinical trials of its use in treatment of leukemia minimal and or residual disease.
    Mathé G; Weiner R; Pouillart P; Schwarzenberg L; Jasmin C; Schneider M; Hayat M; Amiel JL; de Vassal F; Rosenfeld C
    Natl Cancer Inst Monogr; 1973 Dec; 39():165-75. PubMed ID: 4595314
    [No Abstract]   [Full Text] [Related]  

  • 20. Radiation therapy and immunotherapy: the value of immunotherapy in the control of local and regional cancer.
    Cancer; 1976 Apr; 37(4 Suppl):2108-19. PubMed ID: 769945
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.